HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN
Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.
Atropos, the Fate whose duty it was
to cut the threads of life.
Robert S. Holzman, MD
The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998
April 29, 2020
Atropos is pleased to announce the capital support from Incite and LC Global Partners helping us to pursue our goals to identify senomodulators.
Atropos President & Founder, Andy, is interviewed on The Simple Biotech Podcast. >>